AstraZeneca
AZN
#53
Rank
HK$2.272 T
Marketcap
HK$1,465
Share price
-1.43%
Change (1 day)
30.76%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2026 (TTM): HK$54.30

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is HK$54.45. In 2024 the company made an earnings per share (EPS) of HK$35.57 an increase over its 2023 EPS that were of HK$30.09.

EPS history for AstraZeneca from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$54.30
2024HK$35.5718.23%
2023HK$30.0981.13%
2022HK$16.61631.03%
2021HK$2.27-88.11%
2020HK$19.12136.89%
2019HK$8.07-39.41%
2018HK$13.32-28.27%
2017HK$18.57-14.37%
2016HK$21.6824.11%
2015HK$17.47127.55%
2014HK$7.68-51.96%
2013HK$15.98-58.95%
2012HK$38.94-32.2%
2011HK$57.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.45 25.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$55.00 1.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.26-81.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$28.27-48.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$221.14 306.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$20.05-63.17%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$73.26 34.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$27.87-48.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$27.89-48.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$30.45-44.08%๐Ÿ‡ฌ๐Ÿ‡ง UK